SNY Stock Summary and Trading Ideas (Sanofi - American Depositary Shares | NASDAQ:SNY)

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sanofi - American Depositary Shares trades on the NASDAQ stock market under the symbol SNY.

As of October 9, 2026, SNY stock price declined to $40.07 with 2,013,231 million shares trading.

SNY has a beta of 0.17, meaning it tends to be less sensitive to market movements. SNY has a correlation of 0.01 to the broad based SPY ETF.

SNY has a market cap of $95.92 billion. This is considered a Large Cap stock.

Last quarter Sanofi - American Depositary Shares reported $13 billion in Revenue and $1.21 earnings per share. This beat revenue expectation by $832 million and exceeded earnings estimates by $.12.

In the last 3 years, SNY traded as high as $60.12 and as low as $39.18.

The top ETF exchange traded funds that SNY belongs to (by Net Assets): AVDE, FENI, PPH, FVD, PID.

SNY has underperformed the market in the last year with a price return of -12.9% while the SPY ETF gained +16.8%. SNY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.3% and -2.1%, respectively, while the SPY returned +4.7% and +1.5%, respectively.

SNY support price is $39.62 and resistance is $40.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNY shares will trade within this expected range on the day.